Patent application number | Description | Published |
20080251763 | Method For Preparing Phosphor and Phosphor - Disclosed is a method of preparing a phosphor which exhibits superior optical characteristics and improved resistance to deterioration, comprising the steps of subjecting a phosphor precursor obtained by a liquid phase process to a first calcination under an oxygen-containing atmosphere at a prescribed temperature and then subjecting the calcined phosphor precursor to a second calcination at a temperature lower than the temperature of the first calcination. | 10-16-2008 |
20090014688 | Semiconductor Nanoparticles and Manufacturing Method of The Same - A process for the production of semiconductor nanoparticles which realizes both uniform crystallite size and high crystallinity with the agglomeration thereof inhibited. This process is characterized by comprising the step (a) of generating nano-size particles from a semiconductor raw material and dispersing the particles in a gas phase, the step (b) of heat-treating the particles while keeping the particles in a state dispersed in the gas phase, and the step (c) of collecting the heat-treated particles immediately after the heat treatment with a solution of a surface modifier for modifying the surfaces of the particles. | 01-15-2009 |
20090053522 | TRIPLE-LAYER SEMICONDUCTOR NANOPARTICLE AND TRIPLE-LAYER SEMICONDUCTOR NANOROD - A semiconductor nanoparticle and semiconductor nanorod that have optical characteristics (luminescence intensity and emission lifetime) superior to those of conventional core/shell nanosized semiconductors. There are provided a triple-layer semiconductor nanoparticle, and triple-layer semiconductor nanorod, having an average particle diameter of 2 to 50 nm and comprising a core layer, an interlayer and a shell layer, wherein the layers are composed of different crystals, and wherein the crystal constructing the shell layer exhibits a band gap greater than that of the crystal constructing the core layer, and wherein the crystal constructing the interlayer has a lattice constant assuming a value between those of the crystal constructing the core layer and the crystal constructing the shell layer. | 02-26-2009 |
20090236563 | Nanosized Semiconductor Particle Having Core/Shell Structure and Manufacturing Method Thereof - An objective is to provide a nanosized semiconductor particle having a core/shell structure in which a ratio of shell thickness/core portion particle diameter exhibits an optimal ratio in optical properties of optical elements. The particle comprising the structure in which shell portion has a thickness of not more than 1/2 of core portion particle diameter, wherein core portion has a particle diameter of less than 20 nm, and shell portion has a thickness of at least 0.2 nm; core portion has a particle diameter of 20-100 nm, and shell portion has a thickness of at least 1/100 of a core portion particle diameter; core portion possesses at least one element of B, C, N, Al, Si, P, S, Zn, Ga, Ge, As, Se, Cd, In, Sb and Te; and shell portion has a composition exhibiting a larger band gap than that of core portion. | 09-24-2009 |
20090239767 | BIOMOLECULE DETECTION REAGENT AND METHOD FOR DETECTING BIOMOLECULE USING REAGENT - A biomolecule detection reagent comprising semiconductor nanoparticles and magnetic nanoparticles, incorporated in a bead comprising an inorganic compound or an organic polymer, and a surface of the beads is modified with a biomolecule detection molecule. | 09-24-2009 |
20090263659 | SEMICONDUCTOR NANOPARTICLE AND METHOD OF PRODUCING THE SAME - Disclosed is a method to produce a semiconductor nanoparticle which is excellent in monodispersibility and productivity. This method is characterized in that two or more kinds of semiconductor nanoparticles having different average particle diameters are dispersed in a solvent and mixed together, and then subjected to size classification. | 10-22-2009 |
20100038626 | SEMICONDUCTOR NANOPARTICLE AGGREGATE, METHOD FOR PRODUCING THE SAME, AND BIOLOGICAL SUBSTANCE LABELING AGENT UTILIZING THE SAME - This invention provides a semiconductor nanoparticle aggregate comprising three or more types of semiconductor nanoparticles, which are different from each other in diameter, have a narrow particle size distribution, and are different from each other in maximum luminous wavelength of an emission spectrum in a wavelength region of 380 nm to 650 nm, a process for producing the semiconductor nanoparticle aggregate, and a biological substance labeling agent utilizing the semiconductor nanoparticle aggregate. The semiconductor nanoparticle aggregate comprises three or more types of semiconductor nanoparticles which have an identical chemical composition, are different from each other in particle diameter and fall within a particle diameter range of 1.8 to 4 nm and are different from each other in maximum luminous wavelength of an emission spectrum in a wavelength range of 380 to 650 nm. The semiconductor nanoparticle aggregate is characterized in that the difference in maximum luminous wavelength among three or more types of semiconductor nanoparticles constituting the semiconductor nanoparticle aggregate is in the range of 20 to 100 nm. | 02-18-2010 |
20100041017 | FLUORESCENT SEMICONDUCTOR MICROPARTICLE ASSEMBLY, FLUORESCENT LABELING AGENT ASSEMBLY FOR BIOLOGICAL SUBSTANCE, AND BIOIMAGING METHOD AND BIOLOGICAL SUBSTANCE ANALYSIS METHOD USING THE ASSEMBLIES - Disclosed is a fluorescent semiconductor microparticle assembly comprising at least three kinds of fluorescent semiconductor microparticles with an average particle size of from 1 to 10 nm, having the same chemical composition, a different average particle size and a different emission maximum wavelength in the emission spectra, wherein a standard deviation of emission intensity in each of the at least three kinds of fluorescent semiconductor microparticles is not more than 15%. | 02-18-2010 |
20100044673 | LABELING FLUORESCENT COMPOUND - A labeling fluorescent compound which enables highly stable detection in vital labeling and has high sensitivity. The labeling fluorescent compound is characterized by being composed of inorganic fluorescent nanoparticles which have a surface modification compound disposed on the surface thereof and have an average particle diameter of 1.0-20 nm. It is further characterized in that the proportion of the length of the surface modification compound as measured from the surface of the inorganic fluorescent nanoparticles to the particle diameter of the inorganic fluorescent nanoparticles is from 0.10 to 0.50, and that the proportion of the specific gravity of the inorganic fluorescent nanoparticles having the surface modification compound fixed thereto to the specific gravity of the inorganic fluorescent nanoparticles not having the surface modification compound is from 0.80 to 0.40. | 02-25-2010 |
20140186857 | FLUORESCENT LABEL FOR BIOLOGICAL SUBSTANCE DETECTION METHOD - The present invention provides a fluorescent label that can be used for carrying out a biological substance detection method for specifically detecting a biological substance from a pathological specimen, by which method, when immunostaining using a fluorescent label and staining for morphological observation using a staining agent for morphological observation are simultaneously performed, the results of fluorescence observation and immunostaining can be assessed properly even if the fluorescent label and/or the staining agent is/are deteriorated by irradiation with an excitation light. The fluorescent label is a fluorescent dye-containing nanoparticle in which the parent material is a cross-linked polymer and the fluorescent dye is an aromatic ring-based dye molecule. The cross-linked polymer is suitably a melamine resin or a styrene resin. The aromatic ring-based dye molecule is suitably a perylene and more suitably a perylene diimide. The dye molecule can have a polar group such as sulfonic acid group or its acid halide. | 07-03-2014 |
20140212889 | METHOD FOR STAINING TISSUE - It is an object of the present invention to provide a tissue staining method that makes it possible to observe both information on the morphology of a tissue and information on a biological substance such as an antigen molecule to be detected on a single section and in a single view field. The present invention provides a tissue staining method, including carrying out (A) a HE (hematoxylin-eosin) staining, and (B) a histochemical staining, serially on a single tissue section, wherein the histochemical staining is defined as a histochemical technique for detecting a biological substance to be detected in a tissue in a visible manner by use of a binding reaction between the biological substance to be detected and a probe biological substance capable of binding specifically to the biological substance to be detected. | 07-31-2014 |
20150049936 | MEDICAL IMAGE PROCESSOR AND STORAGE MEDIUM - A medical image processor and storage medium are shown. According to one implementation, a medical image processor includes an input unit, an operation unit, a cell nucleus extracting unit, a fluorescent bright point extracting unit, a feature amount calculating unit, and an output unit. The input unit is used to input a cell shape image showing a shape of a cell and a fluorescent image showing expression of a specific protein as a fluorescent bright point. The operation unit is used to specify an analysis target region. The cell nucleus extracting unit extracts a region of a cell nucleus. The fluorescent bright point extracting unit extracts a fluorescent bright point. The feature amount calculating unit calculates a feature amount showing an expression amount of the specific protein. The output unit outputs the calculated feature amount. | 02-19-2015 |